M. Akram
M. Akram (28 March 1934 – 3 April 2016) was a famous Pakistani film director. Provided by Wikipedia
Showing 1 - 16 results of 16 for search 'M. Akram', query time: 0.03s
Refine Results
-
1
The Evolution in Global Power Balance and Pak-China Relations by M. Akram Zaki
Published 2014-01-01
Article -
2
-
3
-
4
-
5
-
6
ASSESSMENT OF DIVERSIFIED VEGETATION COMMUNITY IN ISLAMABAD VICINITY, PAKISTAN by M. Akram, G.H. Abbasi, M. Ahmad, I. Ahmad, M. Jamil, T. Hussain, I. Ashraf, M.A. Sammar Raza
Published 2012-12-01
Article -
7
-
8
Cell Lysis, labeling efficacy and biodistribution of intravenously administered Technetium-99 m labeled multifunctional zirconia nanoparticles in animal model by Ifra SanaUllah, Saira Riaz, Irfan Ullah Khan, Daoud Ali, S. Shamaila, M. Akram Raza, Amna Sajjad, Anjum N. Sabri, Shahzad Naseem
Published 2023-12-01
Article -
9
Role of time-dependent foreign molecules bonding in the degradation mechanism of polymer field-effect transistors in ambient conditions by Muhammad Zohaib, Tahmina Afzal, M. Zahir Iqbal, Badriah S. Almutairi, Mohsin Ali Raza, Muhammad Faheem Maqsood, M. Akram Raza, Saira Riaz, Shahzad Naseem, M. Javaid Iqbal
Published 2023-06-01
Article -
10
P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESS... by H Einsele, AD Cohen, M Delforge, J Hillengass, H Goldschmidt, K Weisel, M-S Raab, C Scheid, JM Schecter, KC De Braganca, H Varsos, T-M Yeh, L Wang, M Vogel, C Corsale, M Akram, L Pacaud, T Nesheiwat, M Agha, YC Cohen
Published 2022-04-01
Article -
11
P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES... by J. Hillengass, A. D. Cohen, M. Delforge, H. Einsele, H. Goldschmidt, K. Weisel, M.-S. Raab, C. Scheid, J. M. Schecter, K. C. De Braganca, H. Varsos, T.-M. Yeh, P. Mistry, T. Roccia, C. Corsale, M. Akram, L. Pacaud, T. Nesheiwat, M. Agha, Y. C. Cohen
Published 2022-06-01
Article -
12
B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND E... by NWCJ van de Donk, M Delforge, M Agha, AD Cohen, YC Cohen, J Hillengass, S Anguille, T Kerre, W Roeloffzen, JM Schecter, KC De Braganca, H Varsos, L Wang, M Vogel, E Zudaire, C Corsale, M Akram, D Geng, T Nesheiwat, L Pacaud, P Sonneveld, S Zweegman
Published 2022-04-01
Article -
13
S185: CARTITUDE-2 COHORT B: UPDATED CLINICAL DATA AND BIOLOGICAL CORRELATIVE ANALYSES OF CILTACABTAGENE AUTOLEUCEL IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL... by M. E. Agha, N. W. van de Donk, A. D. Cohen, Y. C. Cohen, S. Anguille, T. Kerre, W. Roeloffzen, J. M. Schecter, K. C. De Braganca, H. Varsos, P. Mistry, T. Roccia, E. Zudaire, C. Corsale, M. Akram, D. Geng, T Nesheiwat, L. Pacaud, P. Sonneveld, S. Zweegman
Published 2022-06-01
Article -
14
Multi-center implementation of rapid whole genome sequencing provides additional evidence of its utility in the pediatric inpatient setting by Lauren Thompson, Austin Larson, Austin Larson, Lisa Salz, Regan Veith, John-Paul Tsai, Anuj Jayakar, Rachel Chapman, Rachel Chapman, Apeksha Gupta, Stephen F. Kingsmore, David Dimmock, Alan Bedrick, Alan Bedrick, Maureen Kelly Galindo, Kari Casas, Mohamed Mohamed, Lisa Straight, M. Akram Khan, Daria Salyakina
Published 2024-02-01
Article -
15
B09 CARTITUDE-2 COHORT B 18-MONTH FOLLOW-UP: CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH MULTIPLE MYELOMA (MM) AND EARLY RELAPSE AFT... by S. Zweegman, M. Agha, A.D. Cohen, Y.C. Cohen, S. Anguille, T. Kerre, W. Roeloffzen, D. Madduri, J.M. Schecter, K.C. De Braganca, C.C. Jackson, H. Varsos, P. Mistry, T. Roccia, X. Xu, K. Li, E. Zudaire, C. Corsale, M. Akram, D. Geng, L. Pacaud, P. Sonneveld, N. van de Donk
Published 2023-05-01
Article -
16
P28 EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER EXPOSURE TO NON-CELLULAR ANTI-B-CELL MATURATION ANTIGEN (B... by N. van de Donk, M.-V. Mateos, Y.C. Cohen, P. Rodriguez-Otero, B. Paiva, A.D. Cohen, T. Martin, A. Suvannasankha, D. Madduri, C. Corsale, J.M. Schecter, K.C. De Braganca, C.C. Jackson, H. Varsos, W. Deraedt, T. Roccia, P. Mistry, X. Xu, K. Li, E. Zudaire, M. Akram, L. Pacaud, I. Avivi, J. San-Miguel
Published 2023-05-01
Article